Skip to main content

Endovascular Procedures

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Philips
PhilipsNetherlands - Amsterdam
1 program
Neurovascular percutaneous interventionN/A1 trial
Active Trials
NCT03162601Unknown50Est. Nov 2019
Medical Metrics
Medical MetricsTX - Houston
1 program
Saranas Early Bird Bleed Monitoring SystemN/A1 trial
Active Trials
NCT03621202Completed66Est. Jun 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Medical MetricsSaranas Early Bird Bleed Monitoring System
PhilipsNeurovascular percutaneous intervention

Clinical Trials (2)

Total enrollment: 116 patients across 2 trials

NCT03621202Medical MetricsSaranas Early Bird Bleed Monitoring System

Safety and Accuracy of the Saranas EBBMS for the Detection of Endovascular Procedure Related Bleeding Events

Start: Aug 2018Est. completion: Jun 201966 patients
N/ACompleted
NCT03162601PhilipsNeurovascular percutaneous intervention

C-arm Computed Tomography Scan Image Quality in Patients With Neurovascular Diseases

Start: Apr 2017Est. completion: Nov 201950 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.